Clinical Trials on Safety Issues in Peru

Total 471 results

UCB Pharma

Terminated

Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD)

Rheumatoid Arthritis | Crohn's Disease

Russian Federation
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast Cancer

Neoplasms, Breast

France, Belgium, Peru, Italy, Colombia
ETOP IBCSG Partners Foundation

Completed

Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98

Breast Cancer | Osteoporosis

France, Italy, Switzerland, Australia, Peru, Spain, New Zealand, South Africa
GlaxoSmithKline

Completed

Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment

Impetigo

India, Mexico, Netherlands, Italy, Peru
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

Sarcoma | Kidney Cancer | Ovarian Cancer | Metastatic Cancer | Melanoma (Skin)

United States, Australia, Peru, Puerto Rico
AstraZeneca

Completed

LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer (LINE)

Local Advanced or Metastatic Postmenopausal Breast Cancer

Russian Federation
National Cancer Institute (NCI)

Completed

Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery

Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Adult Angiosarcoma

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma

Melanoma (Skin)

United States
Array Biopharma, now a wholly owned subsidiary...

Completed

A Study of ARRY-438162 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Brazil, Argentina, United States, Poland, Hungary, Peru, Romania
Latin American Cooperative Oncology Group
GlaxoSmithKline

Completed

Safety Study in Subjects With Metastatic Breast Cancer Who Progressed After Taxanes Treatment. (GLICO-0801)

BRMS1 | Performance Status Zero to Two for Beginning the Study | Patient With a Maximum of One Chemotherapy | Patient With Progression After Taxanes

Argentina, Brazil, Peru
Chong Kun Dang Pharmaceutical

Completed

A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate

Rheumatoid Arthritis

Czechia, Georgia, Poland, Russian Federation, Ukraine
Pfizer

Completed

Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen

Breast Neoplasms

Belgium, Brazil, United States, India, Peru, Philippines, Mexico, Canada, Colombia
Bristol-Myers Squibb

Completed

Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled Syringe

Rheumatoid Arthritis

Argentina, United States, Peru, South Africa, Mexico
GlaxoSmithKline

Completed

Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer

Neoplasms, Breast

Taiwan, Peru, United States, Hong Kong, Chile, India, Mexico, Poland, Pakistan, Singapore, Malaysia
GlaxoSmithKline
Human Genome Sciences Inc., a GSK Company

Active, not recruiting

Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy (PLUTO)

Systemic Lupus Erythematosus

Peru, United States, Spain, Argentina, United Kingdom, Poland, Canada, Russian Federation, Japan, Mexico
Abbott
Almedis; Scientific Research Institute of Rheumatology, Moscow

Completed

Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care

Rheumatoid Arthritis | Psoriatic Arthritis | Ankylosing Spondylitis

Russian Federation
Hoffmann-La Roche

Completed

A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.

Rheumatoid Arthritis

Colombia, Mexico, Chile, Ecuador, Argentina, Brazil, Peru, Venezuela, Uruguay, El Salvador
Bristol-Myers Squibb

Completed

Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer

Breast Cancer | Metastasis

United States, Spain, Belgium, Peru, Italy, Argentina, France
Fujifilm Kyowa Kirin Biologics Co., Ltd.

Completed

A Study to Compare FKB327 Long-term Safety, Efficacy and Immunogenicity With Humira® in Rheumatoid Arthritis Patients (ARABESC-OLE)

Arthritis, Rheumatoid

Poland, Russian Federation, United States, Germany, Romania, Ukraine, Canada, Chile, Czechia, Spain, Peru
Mallinckrodt

Completed

Acthar Gel for Active Systemic Lupus Erythematosus (SLE)

Lupus Erythematosus, Systemic

United States, Argentina, Mexico, Chile, Peru
Bristol-Myers Squibb

Recruiting

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

Juvenile Idiopathic Arthritis

United States, Germany, Mexico, Peru, Russian Federation, Austria, Brazil, Canada, Denmark, France, Greece, Hungary, Israel, Italy, Latvia, Netherlands, Portugal, Puerto Rico, Romania, Saudi Arabia, Slovakia, South Africa, Spain, United...
Fujifilm Kyowa Kirin Biologics Co., Ltd.

Completed

A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients (ARABESC)

Arthritis, Rheumatoid

United States, Bulgaria, Poland, Russian Federation, Germany, Romania, Ukraine, Canada, Chile, Czechia, Spain, Peru
R-Pharm
Data Management 365; Exacte Labs LLC; Federal State Budgetary Institution "NMIC... and other collaborators

Active, not recruiting

Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms

Head and Neck Squamous Cell Carcinoma | Skin Melanoma | Squamous Non-small-cell Lung Cancer

Russian Federation
Pfizer
Forest Laboratories

Completed

Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections

Complicated Skin and Soft Tissue Infection

United States, Croatia, Australia, Bulgaria, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, South Africa, Spain, Turkey, Philippines, China, Romania, Argentina, Brazil, Chile, Czechia, Israel, Greece, Taiwan, Ukr... and more
Hoffmann-La Roche
Latin American Cooperative Oncology Group

Active, not recruiting

A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America

Breast Cancer

Colombia, Guatemala, Argentina, Brazil, Chile, Cuba, Mexico, Peru, Uruguay, Dominican Republic
Bristol-Myers Squibb

Completed

BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis

Juvenile Rheumatoid Arthritis

United States, Portugal, Italy, Brazil, Germany, Peru, France, Spain, Mexico, Austria, Switzerland
AstraZeneca

Recruiting

HER2(Human Epidermal Growth Factor Receptor 2) -Positive Metastatic Breast Cancer in Russia

Breast Cancer

Russian Federation
MelanomaPRO, Russia
Novartis

Recruiting

pRospective Evaluation of Clinical Outcomes in Patients With metAsTatIс melanOma Treated With dabrafeNib and trAmetinib in reaL practicE (RATIONALE)

Melanoma | Melanoma Stage IV | Melanoma Stage III

Russian Federation
Novartis Pharmaceuticals

Completed

Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis

Moderate to Severe Chronic Plaque-type Psoriasis

Belgium, Spain, Russian Federation, Germany, United States, Czechia, Peru, Poland, Estonia
Pfizer

Completed

An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis

Arthritis, Rheumatoid

Czechia, Poland, Australia, Russian Federation, Spain, Korea, Republic of, Estonia, South Africa, Peru, Brazil, Chile, India
Motif Bio

Completed

Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1 (REVIVE-1)

Skin Structures and Soft Tissue Infections

United States, Bulgaria, Chile, Colombia, Germany, Latvia, Peru, Poland, Puerto Rico, Ukraine
ETOP IBCSG Partners Foundation

Completed

Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer (22-00)

Breast Cancer

Italy, Switzerland, Australia, Peru, South Africa, Chile, Belgium, Brazil, Romania, Hungary, Nigeria
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects

Arthritis, Juvenile Rheumatoid

United States, Serbia, Philippines, Chile, Costa Rica, Peru, Russian Federation, South Africa, Switzerland, Ukraine
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Terminated

Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer

Pain | Breast Cancer | Prostate Cancer

United States, Australia, Peru, Puerto Rico
Hoffmann-La Roche

Completed

Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Participants

Rheumatoid Arthritis

Serbia, Germany, France, Russian Federation, Italy, Tunisia
MediGene

Completed

Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts

Condylomata Acuminata

United States, Argentina, Chile, Colombia, Mexico, Peru, Romania
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Terminated

S9624 Ifosfamide in Treating Patients With Meningeal Tumors

Chondrosarcoma | Adult Rhabdomyosarcoma | Adult Fibrosarcoma | Adult Leiomyosarcoma | Adult Malignant Meningioma | Adult Brain Malignant Hemangiopericytoma

United States, Australia, Peru, Puerto Rico
Galapagos NV

Recruiting

A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus (GALACELA)

Systemic Lupus Erythematosus

United States, Spain, Bulgaria, France, Georgia, Germany, Puerto Rico, Argentina, Poland, Hungary, Chile, Peru
GlaxoSmithKline

Terminated

Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to MTX Therapy

Arthritis, Rheumatoid

Poland, Russian Federation, Argentina, Belgium, Peru, Spain, Australia, Czechia, South Africa, Chile, Hungary, United Kingdom, Romania
Akros Pharma Inc.

Completed

Study to Evaluate Efficacy, Safety and Tolerability of JTE-051 in Subjects With Active Rheumatoid Arthritis (MOVE-RA)

Rheumatoid Arthritis

Ukraine, United States, Argentina, Bulgaria, Romania, Peru, Russian Federation, Mexico, Colombia, Poland
Rigel Pharmaceuticals

Completed

Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3) (Taski-3)

Rheumatoid Arthritis

Belgium, United States, Colombia, France, Germany, Italy, Peru
Kezar Life Sciences, Inc.

Completed

A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis (MISSION)

Systemic Lupus Erythematosus | Lupus Nephritis

United States, Australia, Mexico, Russian Federation, Colombia, Peru, Poland, Ukraine
ETOP IBCSG Partners Foundation

Completed

Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases (23-01)

Breast Cancer

France, Switzerland, Australia, Peru, Italy, New Zealand, Slovenia, Belgium, Brazil, Denmark
Athenex, Inc.

Completed

Ph3 Study To Determine Safety,Tolerability&Tumor Response Of Oraxol Compared To Taxol In Metastatic Breast Cancer

Metastatic Breast Cancer

Argentina, Chile, Colombia, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Panama, Peru
Biocad

Completed

A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer Patients

Human Epithelial Receptor (HER)-2 Positive Breast Cancer

Ukraine, Russian Federation, Belarus, India
MedImmune LLC

Completed

An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults

Lupus Erythematosus, Systemic

United States, Korea, Republic of, Mexico, Peru, Hungary, Ukraine, Czechia, Bulgaria, Colombia, Brazil, Poland, Romania, Taiwan
Genentech, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Poland, United States, Germany, Hungary, Bulgaria, Mexico, Peru, Chile, Romania, Spain
Synta Pharmaceuticals Corp.

Completed

An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer (Enchant)

Breast Cancer | Triple Negative Breast Cancer | HER-2 Positive Breast Cancer | ER/Progressive Response (PR) + Refractory to Prior Hormonal Treatment

Spain, United States, Argentina, Belgium, Brazil, Korea, Republic of, Peru, United Kingdom
Novartis Pharmaceuticals

Recruiting

A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia (PROSPERITY)

Breast Cancer

Russian Federation
AstraZeneca

Completed

Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients (BEECH)

Advanced or Metastatic Breast Cancer | ER+ve Advanced or Metastatic Breast Cancer

Canada, France, Korea, Republic of, Czechia, Peru, United Kingdom, Spain, Japan, Mexico, Singapore, Bulgaria

Clinical Trials on Safety Issues in Peru

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations